W
William C. Schoene
Researcher at Harvard University
Publications - 30
Citations - 1540
William C. Schoene is an academic researcher from Harvard University. The author has contributed to research in topics: Malignancy & Adenoma. The author has an hindex of 17, co-authored 30 publications receiving 1503 citations. Previous affiliations of William C. Schoene include Beth Israel Deaconess Medical Center & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Pituitary carcinoma: a clinicopathologic study of 15 cases.
Peter J. Pernicone,Bernd W. Scheithauer,Thomas J. Sebo,Kalman Kovacs,Eva Horvath,William F. Young,Ricardo V. Lloyd,Dudley H. Davis,Barton L. Guthrie,William C. Schoene +9 more
TL;DR: Pituitary carcinomas are rare adenohypophysial neoplasms, the definition, diagnosis, therapy, and prognosis of which are controversial.
Journal ArticleDOI
Hallervorden-Spatz syndrome.
TL;DR: Two sisters with Hallervorden-spatz syndrome (HSS) were treated with anti-Parkinson drugs and showed the typical neuropathological lesions at death as mentioned in this paper.
Journal ArticleDOI
Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas
Jay S. Loeffler,Eben Alexander,Fred H. Hochberg,Patrick Y. Wen,James Morris,James Morris,William C. Schoene,William C. Schoene,Robert L. Siddon,Robert H. Morse,Peter McL. Black +10 more
TL;DR: St stereotactic interstitial irradiation has changed the recurrence pattern in patients with malignant glioma with true local recurrence no longer being the predominant pattern of failure as is seen with conventional therapy.
Journal ArticleDOI
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy.
Journal ArticleDOI
Malignant transformation in benign cerebellar astrocytoma: Case report
TL;DR: In this paper, the authors give follow-up information on Case 59 of Cushing's 1931 series of cerebellar astrocytomas and show that even with incomplete resections patients have survived for years without progression of the tumor.